Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol plus remifentanil for anesthesia maintenance in elderly patients undergoing TURP
ChiCTR2300074156Phase 4Not yet recruiting
- Sponsor
- Deyang People's Hospital
- Start
- Jun 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam, propofol and remifentanil in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Deyang People's Hospital. Primary endpoints: Time to recovery from anesthesia or time to removal of laryngeal mask, Induction time of anesthesia and 1 more. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
remimazolampropofolremifentanil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on ChiCTR2300074156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074156.